Latest Breaking News On - Kalipada pahan - Page 4 : comparemela.com

 E-Mail A new therapy developed by researchers at Rush University Medical Center is showing success as a way to prevent COVID-19 symptoms in mice. In a study published in the Journal of Neuroimmune Pharmacology, mouse models with COVID-19 showed positive results when a small peptide was introduced nasally. The peptide proved effective in reducing fever, protecting the lungs, improving heart function and reversing cytokine storm a condition in which an infection triggers the immune system to flood the bloodstream with inflammatory proteins. The researchers also report success in preventing the disease from progression. This could be a new approach to prevent SARS-CoV-2 infection and protect COVID-19 patients from breathing problems and cardiac issues, said Kalipada Pahan, PhD, the Floyd A. Davis Professor of Neurology at Rush and a Research Career Scientist at the Jesse Brown VA Medical Center. Understanding the mechanism is proving important to developing effective therapi

United statesMalabendu janaKalipada pahanSumita rahaDebashis duttaRamak mishraRamesh kumarFloyda davisRush university medical centerJesse brown va medical centerResearch career scientistNorthwestern universityNeuroimmune pharmacologyJesse brownMedicine healthClinical trials